192 related articles for article (PubMed ID: 16958555)
1. Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences.
Mégarbane B; Hreiche R; Pirnay S; Marie N; Baud FJ
Toxicol Rev; 2006; 25(2):79-85. PubMed ID: 16958555
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
Lugoboni F; Zamboni L; Cibin M; Tamburin S;
Eur Addict Res; 2019; 25(1):10-19. PubMed ID: 30625491
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of death probably triggered by the association of buprenorphine at therapeutic dose with ethanol and benzodiazepines and with very low norbuprenorphine level.
Bardy G; Cathala P; Eiden C; Baccino E; Petit P; Mathieu O
J Forensic Sci; 2015 Jan; 60 Suppl 1():S269-71. PubMed ID: 25348172
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
[TBL] [Abstract][Full Text] [Related]
9. Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice.
Alhaddad H; Cisternino S; Declèves X; Tournier N; Schlatter J; Chiadmi F; Risède P; Smirnova M; Besengez C; Scherrmann JM; Baud FJ; Mégarbane B
Crit Care Med; 2012 Dec; 40(12):3215-23. PubMed ID: 22975888
[TBL] [Abstract][Full Text] [Related]
10. Editor's Highlight: Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat.
Cohier C; Chevillard L; Salle S; Risède P; Roussel O; Mégarbane B
Toxicol Sci; 2017 Feb; 155(2):389-399. PubMed ID: 27803387
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine induces ceiling in respiratory depression but not in analgesia.
Dahan A; Yassen A; Romberg R; Sarton E; Teppema L; Olofsen E; Danhof M
Br J Anaesth; 2006 May; 96(5):627-32. PubMed ID: 16547090
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats.
Dahan A; Yassen A; Bijl H; Romberg R; Sarton E; Teppema L; Olofsen E; Danhof M
Br J Anaesth; 2005 Jun; 94(6):825-34. PubMed ID: 15833777
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine: a treatment and cause of opioid-induced respiratory depression.
Dahan A; van Lemmen M; Jansen S; Simons P; van der Schrier R
Br J Anaesth; 2022 Mar; 128(3):402-404. PubMed ID: 34996591
[TBL] [Abstract][Full Text] [Related]
15. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine TTS for children--a review of the drug's clinical pharmacology.
Michel E; Anderson BJ; Zernikow B
Paediatr Anaesth; 2011 Mar; 21(3):280-90. PubMed ID: 21091589
[TBL] [Abstract][Full Text] [Related]
17. Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine
.
Strang J; Knight A; Baillie S; Reed K; Bogdanowicz K; Bell J
Int J Clin Pharmacol Ther; 2018 Feb; 56(2):81-85. PubMed ID: 29231163
[TBL] [Abstract][Full Text] [Related]
18. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
Bramness JG; Bachs LC; Waal H
Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment.
Mégarbane B; Buisine A; Jacobs F; Résière D; Chevillard L; Vicaut E; Baud FJ
J Subst Abuse Treat; 2010 Jun; 38(4):403-7. PubMed ID: 20189341
[TBL] [Abstract][Full Text] [Related]
20. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.
Ding H; Czoty PW; Kiguchi N; Cami-Kobeci G; Sukhtankar DD; Nader MA; Husbands SM; Ko MC
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5511-8. PubMed ID: 27573832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
